12 November 2019
Anifrolumab achieved a statistically significant reduction in disease activity, a statistically significant reduction in oral corticosteroid use and improvement in skin manifestations…
ITV Plc Issue Third Quarter Trading Update for 9 months dated 30 September 2019 – ITV on track to deliver full year guidance…
B&M European Value Retail S.A. (“the Group”), the UK's leading variety goods value retailer, today announces its interim results for the 26 weeks to 29 September 2019….
Land Securities Group Plc issue Half-year results for the six months ended 30 September 2019 – Strong operational metrics and increased development activity in London…
11 November 2019
Greggs Plc issue strong trading update for the six weeks to 9th November 2019…
Carr's group Plc issue full year results for the year ended 31 August 2019…
Dignity Plc (Dignity, the Company or the Group), the UK's only listed provider of funeral related services, announces its trading update for the third quarter of 2019….
8 November 2019
AstraZeneca today presented detailed results from the Phase III OLYMPUS and ROCKIES trials showing that roxadustat significantly increased haemoglobin (Hb) levels in non-dialysis-dependent (NDD) and dialysis-dependent (DD) patients with anaemia from chronic kidney disease (CKD), respectively….